Crossmark

Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types

Published Online: 2024-12-23

Authors

Xu, Peiyi

Zhang, Qiuyan

Zhai, Jing

Chen, Pu

Deng, Xueting

Miao, Lin

Zhang, Xiuhua
Funding

Funding for this research was provided by:

Xueting Deng (82171222)
License Information

Text and Data Mining valid from 2024-12-23

Version of Record valid from 2024-12-23
More Information

Article History

Received: 13 June 2024

Accepted: 11 December 2024

First Online: 23 December 2024

Declarations

:

: The manuscript contains no clinical trials or patient data.

: Not applicable.

: The authors declare no competing interests.

Document is current